Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.04 USD | -9.79% | -13.14% | -5.30% |
Mar. 18 | Allogene Therapeutics, Inc.(NasdaqGS:ALLO) added to S&P Biotechnology Select Industry Index | CI |
Mar. 15 | Allogene Therapeutics Files $500 Million Mixed Shelf | MT |
Financials (USD)
Sales 2024 * | 42.75K | Sales 2025 * | 4.12M | Capitalization | 575M |
---|---|---|---|---|---|
Net income 2024 * | -283M | Net income 2025 * | -305M | EV / Sales 2024 * | 7,610 x |
Net cash position 2024 * | 250M | Net cash position 2025 * | 284M | EV / Sales 2025 * | 70.8 x |
P/E ratio 2024 * |
-1.81
x | P/E ratio 2025 * |
-1.83
x | Employees | 233 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.49% |
Latest transcript on Allogene Therapeutics, Inc.
1 day | -9.79% | ||
1 week | -13.14% | ||
Current month | -31.99% | ||
1 month | -28.64% | ||
3 months | -5.30% | ||
6 months | +9.35% | ||
Current year | -5.30% |
Managers | Title | Age | Since |
---|---|---|---|
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
David Chang
FOU | Founder | 64 | 18-03-31 |
Geoffrey Parker
DFI | Director of Finance/CFO | 59 | 23-10-15 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Bonderman
BRD | Director/Board Member | 81 | 18-04-30 |
Joshua Kazam
FOU | Founder | 47 | 17-10-31 |
Arie Belldegrun
FOU | Founder | 74 | 17-10-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
3.54% | 2 M€ | -25.75% | ||
0.08% | 0 M€ | 0.00% | - | |
0.06% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-24 | 3.04 | -9.79% | 2,107,565 |
24-04-23 | 3.37 | -0.88% | 1,606,762 |
24-04-22 | 3.4 | -2.02% | 1,789,993 |
24-04-19 | 3.47 | +0.29% | 2,013,218 |
24-04-18 | 3.46 | -1.42% | 1,245,819 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.30% | 570M | |
-1.51% | 105B | |
+3.22% | 97.5B | |
+1.86% | 22.19B | |
-16.53% | 21.33B | |
-8.49% | 18.68B | |
-42.33% | 16.6B | |
-20.09% | 14.52B | |
+5.47% | 14.09B | |
+28.85% | 10.99B |
- Stock Market
- Equities
- ALLO Stock